Enhanced aircraft and engine health monitoring debuts on Bombardier’s Global 5500 and 6500 business aircraft - Rolls-Royce plc

Take a look through some of the notable data presentations at this year's ESMO Congress. Related to this articleOctober 14th, 2026Delayed diagnosis and skipped nodal staging worsen penile cancer outcomes, according to Luis G. Medina, MD. Read moreOctober 20th, 2026The investigational HIF-2α inhibitor casdatifan demonstrated antitumor activity as monotherapy and in combination regimens across the ARC-20 platform study. Read moreOctober 19th, 2026The agency issued a PDUFA target action date of June 14, 2027. Read moreOctober 19th, 2026Jeffrey M. Spier, MD, reviews evidence on ARPI dose reduction in prostate cancer and discusses monitoring treatment response, tolerability, and dose reescalation. Read moreOctober 19th, 2026Jeffrey M. Spier, MD, discusses managing ARPI-related fatigue through dose adjustments, patient monitoring, and strategies to maintain treatment adherence. Read moreOctober 16th, 2026Long-term QUILT-3.032 findings show durable responses with Anktiva plus BCG in BCG-unresponsive NMIBC, with an estimated 84.2% cystectomy-free survival at 3 years.